Series date: 
01/01/2023 - 7:30am to 12/31/2023 - 7:30am

DESCRIPTION
Nephrology Hypertension Grand Rounds - This series is held weekly on Tuesday, 7:30 - 8:30 a.m in Gonda 19-101.

Consultants, fellows and visiting professors present a 45 minute discussion topic which is intended to be a comprehensive review after which there is a 10-15 minute period for questions.  These "state-of-the-art" lectures are directed at the faculty and fellow level.  

TARGET AUDIENCE
The audience is primarily the physicians in our division, but all members of the division, i.e. nurses, NP/PAs and allied health staff are encouraged to attend.  We advertise the Grand Rounds title and speaker name throughout the institution which allows other areas/divisions to attend if they wish.  

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

•    Integrate recent developments in Nephrology and Hypertension to their current practice.
•    Review basic mechanisms of disease and determine potential treatment target.
•    Compare and critique various diagnostic as well as treatment strategies.
•    Summarize rationale for drug treatment choices.
•    Debate with colleagues best practices and current standard of care.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Hatem Amer, M.D. - Grant/Research Support - Kaneka Pharma
John C. Lieske, M.D. - Grant/Research Support - Alnylam, NovoNordisc, Numares

All relevant financial relationships listed for these individuals have been mitigated.

No relevant financial relationship(s) with ineligible companies:
Robert C. Albright, D.O.; James R. Gregoire, M.D.; Kianoush Kashani, M.D.; Sandra J. Taler, M.D.; Ladan Zand, M.D.; Melissa L. Hanson, Jacqlyn (Jackie) A. Oakland, Kathy Hegna Zelinske

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

All relevant financial relationships have been mitigated. 

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

COURSE DIRECTOR(S)
Ladan Zand, M.D.

QUESTIONS?
Contact Kathy Hegna Zelinske at phone 6-1044 OR Jacqlyn Oakland at phone 4-3479

*Required Information for Accreditation is posted in Outlook Calendar Invitation.

Support location: 
Minnesota

Sessions

Session Date
Nephrology Hypertension Grand Rounds Leveraging EHR for Research and Practice: January 10, 2023 01/10/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds M&M - The Case of The Obscure Anemia - January 17, 2023 01/17/2023 - 7:30am to 8:30am
(Nephrology Hypertension Grand Rounds) Getting Dialysis Wrong, Newly Appreciated Ways We Hurt Our Patients: January 24, 2023 01/24/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds Congestion and Volume Overload in Critically Ill Patients January, 31, 2023 01/31/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds Recurrent Glomerular Disease Post Transplantation Overview 02/07/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds, From Molecules to Mentorship: Advancing Nephrology Locally and Globally (February, 14, 2023) 02/14/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds Point of Care Ultrasound Enhanced Physical Examination for Volume Status Assessment: February 21, 2023 02/21/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds, Transplant Metabolic Bariatric Program for Kidney Transplant Candidates at Mayo Clinic, Rochester: February 28, 2023 02/28/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds, Bicarbonate Transporters: The Kidney, Why We Care, and How to Study Them March 7, 2023 03/07/2023 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds, Quality Improvement Projects, March 14, 2023 03/14/2023 - 7:30am to 8:30am

Pages